Uniphos Enterprises DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.99×0.99×1.23×0.99×0.99×
−4.28×−4.73×−0.05×−9.93×−11.43×
−18.2%−13.8%−4.1%−7.7%−235.4%
0.01×0.01×0.05×0.02×0.00×
1.07×1.07×1.04×1.00×1.03×
0.8%0.7%0.0%1.5%0.0%
0.8%0.8%0.0%1.5%1.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

UNIENTER₹85.24

Uniphos Enterprises Limited

· Chemicals
₹ CrorePeersVINYLINDIASRDMcap ₹593 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.990.991.230.990.99
Interest Burden (Pretax/EBIT) ×-11.43-9.93-0.05-4.73-4.28
EBIT Margin %-235.42-7.75-4.10-13.76-18.19
Asset Turnover ×0.000.020.050.010.01
Financial Leverage (Assets/Equity) ×1.031.001.041.071.07
ROE (5-step product, year-end total equity) %0.001.530.010.690.83
ROE (owners' profit / average owners' equity) %1.271.520.010.800.80
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.